UB Paderborn / Katalog / Suche / in CDI

1 – 11 von 11

Sortiert nach

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

Journal of hematology and oncology, 2020-11, Vol.13 (1), p.145-145, Article 145

2020

Volltextzugriff (PDF)

Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy

Journal of controlled release, 2020-06, Vol.322, p.530-541

2020

Volltextzugriff (PDF)

Identification of a moderate affinity CD22 binding peptide and optimization of peptide-targeted nanoparticles for selective uptake by CD22+ B-cell malignancies

Nanoscale, 2020-06, Vol.12 (21), p.11672-11683

2020

Volltextzugriff (PDF)

Identification of a moderate affinity CD22 binding peptide and in vitro optimization of peptide-targeted nanoparticles for selective uptake by CD22+ B-cell malignancies

Nanoscale, 2020-06, Vol.12 (21), p.11672-11683

2020

Volltextzugriff (PDF)

How could nanoallergen technology be used as a diagnostic tool for allergies?

Nanomedicine (London, England), 2020-05, Vol.15 (11), p.1063-1066

2020

Volltextzugriff (PDF)

A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78

Nanoscale, 2023-08, Vol.15 (32), p.13322-13334

2023

Volltextzugriff (PDF)

Nanoallergen platform for detection of platin drug allergies

Journal of allergy and clinical immunology, 2019-05, Vol.143 (5), p.1957-1960.e12

2019

Volltextzugriff (PDF)

Design of Optimized Peptide-Targeted Nanoparticles for Accomplishment of Selective Drug Delivery to Cancer Cells and Development of Inhibitors for Food Allergic Reactions

Kim, Baksun

2020

Volltextzugriff (PDF)

Nanoallergen Platform for the Detection of Platin Drugs Allergies

Journal of allergy and clinical immunology, 2019-01, Vol.143 (5), p.1957-1960.e12

2019

Volltextzugriff (PDF)

Covalent Heterobivalent Inhibitor Design for Inhibition of IgE-Dependent Penicillin Allergy in a Murine Model

The Journal of immunology (1950), 2019-07, Vol.203 (1), p.21-30

2019

Volltextzugriff (PDF)

Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergen

Proceedings of the National Academy of Sciences - PNAS, 2019-04, Vol.116 (18), p.8966-8974

2019

Volltextzugriff (PDF)

1 – 11 von 11

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10)
Mit Volltextzugriff
(9)

Publikationsform

Artikel
(10)
Dissertationen
(1)

Sprache

Englisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy

Identification of a moderate affinity CD22 binding peptide and optimization of peptide-targeted nanoparticles for selective uptake by CD22+ B-cell malignancies

Identification of a moderate affinity CD22 binding peptide and in vitro optimization of peptide-targeted nanoparticles for selective uptake by CD22+ B-cell malignancies

How could nanoallergen technology be used as a diagnostic tool for allergies?

A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78

Nanoallergen platform for detection of platin drug allergies

Design of Optimized Peptide-Targeted Nanoparticles for Accomplishment of Selective Drug Delivery to Cancer Cells and Development of Inhibitors for Food Allergic Reactions

Nanoallergen Platform for the Detection of Platin Drugs Allergies

Covalent Heterobivalent Inhibitor Design for Inhibition of IgE-Dependent Penicillin Allergy in a Murine Model

Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergen

Suchergebnisse filtern